Dose Escalation and Efficacy Study of mRNA-2416 for Intratumoral Injection Alone and in Combination With Durvalumab for Participants With Advanced Malignancies
Clinical trial NCT03323398 · TERMINATED
Trial details
- NCT number
- NCT03323398
- Sponsor
- ModernaTX, Inc.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-15
- Primary completion
- 2021-08-18
- Enrollment
- 79
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.